Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
3.370
+0.010 (0.30%)
Nov 22, 2024, 4:00 PM EST - Market closed
Clover Health Investments Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for CLOV stock has a target of 4.00, which predicts an increase of 18.69% from the current stock price of 3.37.
Analyst Consensus: Hold
* Price targets were last updated on Oct 7, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for CLOV is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Initiates $4 | Hold | Initiates | $4 | +18.69% | Oct 7, 2024 |
| Citigroup | Citigroup | Hold Maintains $1 → $1.5 | Hold | Maintains | $1 → $1.5 | -55.49% | Aug 11, 2023 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $4 → $3 | Strong Buy | Maintains | $4 → $3 | -10.98% | Mar 6, 2023 |
| Credit Suisse | Credit Suisse | Sell Maintains $2.5 → $1.25 | Sell | Maintains | $2.5 → $1.25 | -62.91% | Mar 6, 2023 |
| Citigroup | Citigroup | Hold Maintains $3.5 → $1.8 | Hold | Maintains | $3.5 → $1.8 | -46.59% | Nov 16, 2022 |
Financial Forecast
Revenue This Year
1.41B
Revenue Next Year
1.60B
from 1.41B
Increased by 13.32%
EPS This Year
-0.13
from -0.44
EPS Next Year
-0.14
from -0.13
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.5B | 1.7B | 2.0B | ||
| Avg | 1.4B | 1.6B | 1.9B | ||
| Low | 1.4B | 1.5B | 1.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 19.2% | 26.3% | ||
| Avg | - | 13.3% | 17.5% | ||
| Low | - | 6.4% | 9.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.13 | -0.07 | -0.11 | ||
| Avg | -0.13 | -0.14 | -0.12 | ||
| Low | -0.14 | -0.19 | -0.15 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.